Quick Takeaways
- This page summarizes Linda M. Richardson's Form 4 filing for INTERCEPT PHARMACEUTICALS, INC..
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 17 Aug 2022, 16:01.
Linda M. Richardson - 15 Aug 2022 Form 4 Insider Report for INTERCEPT PHARMACEUTICALS, INC.
- Signature
- /s/ Rocco Venezia, as attorney-in-fact
- Issuer symbol
- N/A
- Transactions as of
- 15 Aug 2022
- Net transactions value
- -$2,256
- Form type
- 4
- Filing time
- 17 Aug 2022, 16:01:37 UTC
- Previous filing
- 17 May 2022
- Next filing
- 06 Sep 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Linda M. Richardson filed Form 4 for INTERCEPT PHARMACEUTICALS, INC. on 17 Aug 2022."
What Changed
- Previous filing in this sequence was filed on 17 May 2022.
- Current net transaction value: -$2,256.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ICPT | Common Stock | Tax liability | $2,256 | -124 | -0.37% | $18.19 | 33,674 | 15 Aug 2022 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person. |